Acrocyanosis induced by interferon α(2a)

Dermatology

Volumn 196, Issue 3, 1998, Pages 361-363

  Campo Voegeli, Antonio ^a   Estrach, T ^a   Marti, R M ^a   Corominas, N ^a   Tuset, M ^a   Mascaro J M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Acrocyanosis; Antinuclear antibodies; Interferon (2a); Long term side effect

Indexed keywords

ANTINUCLEAR ANTIBODY; ETRETINATE; RECOMBINANT ALPHA2A INTERFERON;

ACROCYANOSIS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PUVA;

ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; FEMALE; HAND; HUMANS; INTERFERON-ALPHA; MIDDLE AGED; MYCOSIS FUNGOIDES; RAYNAUD DISEASE; SKIN NEOPLASMS;

EID: 0031966734     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017917     Document Type: Article

References (22)

1. Kloke O, May D, Niederle N: Zur Dosierung von Interferon alpha in der Induktions- und Erhaltungstherapie der Haarzellenleukämie. Onkologie 1988;11(suppl 2):41-45.
2. May D, Wandl UB, Niederle N: Treatment of essential thrombocythemia with interferon α-2b. Lancet 1989;i:96.
3. Wandl UB, Opalka B, Kloke O, Nagel-Hiemke M, Moritz T, Niederle N: Treatment of chronic myelogenous leukemia by different cytokines. Semin Oncol 1992;19(suppl 4):88-94.
4. Bunn PA, Fonn KA, Inde DC, Longo DL, Eddy J, Winkler CF, Veach SR: Recombinant leukocyte A interferon: An active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 1984;101:484-487.
5. Kirkwood JM, Stradwderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Onoclogy Group Trial EST 1684. J Clin Oncol 1996;14:7-17.
6. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU: Clinical toxicity of interferons in cancer patients: A review. J Clin Oncol 1986;4:234-243.
7. Akard LP, Hoffman R, Elias L, Saiers JH: Alpha-interferon and immune hemolytic anemia. Ann Intern Med 1986;105:306.
8. McLaughlin P, Talpaz M, Quesada JR, Saleem A, Barlogie B, Gutterman JU: Immune thrombocytopenia following cc-interferon therapy in patients with cancer. JAMA 1985;254:1353-1354.
9. Burman P, Tötterman TH, Öberg K, Karlsson FA: Thyroid autoimmunity in patients on long-term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab 1986;63:1086-1090.
10. Rönnblom LE, Alm GV, Öberg KE: Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990;227:207-210.
11. Machold KP, Smolen JS: Interferon-gamma induced exacerbation of systemic lupus erythematosus. J Rheumatol 1990;17:831-832.
12. Panitch HS, Hirsch RL, Haley AS, Johnson KF: Exacerbation of multiple sclerosis in patients treated with interferon-γ. Lancet 1987;2:893-895.
13. Wandl UB, Nagel-Hiemke M, May D, Kreuzfelder E, Kloke O, Kranzhoff M, Seeber S, Niederle N: Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol 1992;65:70-74.
14. Salud A, Solans R, Pérez C, Fonollosa V, Felip E, Capdevila F, Rubio D: Antinuclear antibodies in neoplastic patients. Eur J Cancer 1991;27(suppl 2):262.
15. Roy V, Newland AC: Raynaud's phenomenon and cryoglobulinaemia associated with the use of recombinant human alpha interferon. Lancet 1988;i:944.
16. Creutzig A, Freund M: Severe Raynaud's syndrome associated with interferon therapy. Angiology 1996;47:185-187.
17. Bachmeyer C, Farge D, Gluckman E, Miclea JM, Aractingi S: Raynaud's phenomenon and digital necrosis induced by interferon-alpha. Br J Dermatol 1996;135:481-483.
18. Creutzig A, Caspary L, Freund M: The Raynaud phenomenon and interferon therapy. Ann Intern Med 1996;125:423.
19. Cozzolino F, Platt J,Torcia M: Interferon ́ and interleukin 2 synergistically enhance basic fibroblast growth factor and induce release promoting endothelial cell growth. J Clin Invest 1993;91:2504-2512.
20. Blaheta RA, Scholz M, Hailer NP: Adhesion and penetration properties of human lymphocytes acting on allogeneic endothelial cells. Immunology 1994;81:538-545.
21. Pearce I, Pearce JMS: Bromocriptine in parkinsonism. Br Med J 1978;1:1402-1404.
22. Durvoisin RC: Digital vasospasm with bromocriptine. Lancet 1976;ii:204.